<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>MOLECULAR CELLULAR BIOLOGY, Nov. 2008, p. 6939&#226;&#8364;&#8220;6953                                                                           Vol. 28,  22 <br /> 0270-7306/08/$08.00&#226;&#171;&#185;0 doi:10.1128/MCB.01115-08 <br /> Copyright &#194;&#169; 2008, American Society Microbiology. Rights Reserved. <br />  <br />  <br />  KREPA3 Zinc Finger Motifs OB-Fold Domain Essential <br />       RNA Editing Survival Trypanosoma brucei&#228;&#338;&#164; <br />                             Xuemin Guo,1 Nancy Lewis Ernst,1 Kenneth D. Stuart1,2* <br />                  Seattle Biomedical Research Institute, Seattle, Washington 98109,1 Department Pathobiology, <br />                                        University Washington, Seattle, Washington 981952 <br />                         Received 15 July 2008/Returned modification 14 August 2008/Accepted 3 September 2008 <br />  <br />              types editosomes, identical core containing related KREPA proteins, catalyze U <br />           insertion deletion RNA editing mitochondrial mRNAs trypanosomes. Repression expression            KREPA3  known TbMP42), shows essential growth vivo editing procyclic <br />           (PF) bloodstream (BF) life cycle stages Trypanosoma brucei. RNA interference knockdown results           editosome disruption altered vitro editing PFs, repression regulatable double knockout results <br />           complete loss editosomes BFs. Mutational analysis shows KREPA3 zinc fingers OB-fold <br />           domain essential growth vivo editing.  KREPA3 mutated zinc fingers <br />           incorporates editosomes catalyze vitro editing essential editosome integrity,           stability affected. contrast, OB-fold domain essential editosome integrity. Overall, KREPA3, espe- <br />           cially OB-fold, functions editosome integrity, zinc fingers essential editing vivo           central catalytic steps. KREPA3 function editosome organization RNA positioning. <br />  <br />  <br />    RNA editing trypanosomes creates mature mitochondrial                    proteins associated complexes (mt) mRNAs insertion deletion uridylates (U&#226;&#8364;&#8482;s)                   identified function accessory factors. specified sequences small guide RNAs (gRNAs)                         types editosomes distinct editing site <br /> (6, 52). employs multiprotein complexes,                     cleavage specificities. distinct endonucle- editosome sediments &#226;&#172;&#402;20S glycerol                      ase, KREN1, KREN2 KREN3, unique <br /> gradients contains enzymes catalyze key cat-                  proteins, identical &#226;&#8364;&#339;core&#226;&#8364;? proteins (Fig. 1) (11, <br /> alytic steps pre-mRNA cleavage, U insertion deletion,                    38). identical &#226;&#8364;&#339;core&#226;&#8364;? contains related type kineto- RNA ligation (32, 50, 53). pre-mRNA par-                       plastid RNA editing proteins (KREPA1 KREPA6), tially duplexed gRNA 3&#226;&#172;&#732; editing site (ES),                   C-terminal OB-fold domain, larg- editing occurs cycles enzymatic steps. pre-                    est (KREPA1, -A2, -A3) C2H2 zinc finger <br /> mRNA cleaved ES KREN1 endonuclease                       (ZF) motifs (39, 62). KREPA1 KREPA2 form dif- specific deletion sites KREN2 KREN3,                     ferent heterotrimeric subcomplexes vivo vitro specific different insertion sites. U&#226;&#8364;&#8482;s                catalyze postcleavage steps insertion deletion edit- <br /> added 5&#226;&#172;&#732; mRNA fragment KRET2 3&#226;&#172;&#732; terminal                         ing, respectively (14, 15, 19, 28, 37, 47, 53). KREPA1 associates <br /> uridylyl transferase U&#226;&#8364;&#8482;s removed KREX1                        KRET2 KREL2 resulting insertion subcomplex <br /> KREX2 3&#226;&#172;&#732; exonuclease, number added removed                      adds U&#226;&#8364;&#8482;s ligates products specified U&#226;&#8364;&#8482;s specified gRNA sequence. processed 5&#226;&#172;&#732; frag-                     gRNA. Similarly, KREPA2 associates KREX2 ment religated 3&#226;&#172;&#732; fragment KREL1                    KREL1 deletion subcomplex catalyzes U removal KREL2 RNA ligase (3, 10&#226;&#8364;&#8220;12, 15, 16, 27, 45, 48, 56). Multiple                  ligation specified gRNA. binary interactions cycles editing extend pre-mRNA/gRNA du-                       proteins specific enzymes enhance catalytic <br /> plex, generally 5&#226;&#172;&#732; direction, completely                 activity  KREPA proteins appear play roles complementary. editing mRNAs requires multiple                     architecture function editosomes. Loss <br /> gRNAs specifying editing 3&#226;&#172;&#732; regions                     expression KREPA1, KREPA2, KREPA4, KREPA6 <br /> creating pre-mRNA sequence complementary                      proteins results partial complete loss editosomes (19, <br /> 5&#226;&#172;&#732; &#226;&#8364;&#339;anchor&#226;&#8364;? sequence subsequent gRNA providing                     29, 37, 46, 54). Brecht et al. (8) reported recombinant orderly use. complexes involved editing,                KREPA3 binds double-stranded RNA (dsRNA) dsDNA <br /> including MRP1/MRP2, RBP16, TbRGG1, RET1                               endo-exo-RNase activity localizes OB-fold <br /> complexes, appear preprocess traffic mRNAs <br />                                                                                domain knockdown little effect 20S editosome gRNAs regulate editing (2, 33, 34, 42, 57).                                                                                integrity.  Law et al. (30) KREPA3                                                                                important editosome stability endonuclease activity                                                                                U addition, U removal, RNA ligase activities.                                                                                findings resolved identi- <br />   * Corresponding author. Mailing address: Seattle Biomedical               fication editing endonucleases U-specific exo- <br /> search Institute, 307 Westlake Avenue North, Suite 500, Seattle, WA <br /> 98109. Phone: (206) 256-7316. Fax: (206) 256-7229. E-mail: ken.stuart <br />                                                                                nucleases (10, 11, 27, 45, 56) reflect experimental <br /> @sbri.org.                                                                     differences, roles KREPA3 affect editosome <br />   &#228;&#338;&#164; <br />     Published ahead print 15 September 2008.                             structure enzymatic activities. <br />  <br />                                                                         6939 <br />  6940     GUO ET AL.                                                                                                               MOL. CELL. BIOL. <br />  <br />  <br />                                                                       gRNA oligo(U) tail hypothesized use OB-fold <br />                                                                       domain coordinate forward progression RNA editing <br />                                                                       steps (46, 54). OB-fold KREPA3 proposed                                                                       RNA recognition ribonucleolytic activities (8, 36). <br />                                                                          KREPA3 essential RNA editing <br />                                                                       survival PF BF parasites.                                                                       KREPA3 important editosome integrity knock- <br />                                                                       downs PFs generate smaller complexes U addition, <br />                                                                       U removal, ligation steps editing characteristic <br />                                                                       heterotrimeric insertion deletion editosome sub- <br />                                                                       complexes. KREPA3 bridges subcom- <br />                                                                       plexes editosome core. deletion insertion <br />   FIG. 1. Schematic representation 20S editosomes.     endonucleolytic activities reduced associated editosomes consists common core proteins (rectangle)    &#226;&#172;&#402;20S editosomes. transcriptional insertion subcomplex consisting KREPA1, KRET2,         inactivation KREPA3 BFs, appears complete <br /> KREL2 deletion subcomplex KREPA2, KREX2, KREL1. KREPA3 core editosomes (bold).           RNA interference (RNAi) knockdown, results essen- <br /> editosome different endonuclease, KREN1, KREN2,              tially complete loss editosomes vitro catalytic <br /> KREN3 (N1-3) unique KREPB protein (B6-7). KREN1            activities. Exclusive expression KREPA3 proteins mu- <br /> editosomes contain KREX1 (X1). KREN1 deletion endonuclease            tations ZFs deletion OB-fold resulted <br /> editosomes contain KREPB8 KREX1, KREN2 insertion endo- <br />                                                                       ablation RNA editing vivo cell death. Tagged <br /> nuclease editosomes contain KREPB7, KREN3 insertion  <br /> donuclease editosomes contain KREPB6. KREH1 helicase           KREPA3 ZFs mutated incorporate &#226;&#172;&#402;20S biochemically TAP tag-purified editosomes.           editosomes, catalyze activities vitro.  <br />                                                                       trast, tagged KREPA3 OB-fold deleted does  <br />                                                                       corporate editosomes rescue &#226;&#172;&#402;20S editosomes    C2H2-ZF proteins display diversity ZF number, position          loss wild-type (WT) KREPA3.  ZFs OB-fold protein, <span id='am-34' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-35' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-37' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-38' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-39' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span>amino acid</span> spacing, flanking sequence,         domain indispensable KREPA3 function vivo.  ligands include dsDNA, dsRNA, DNA-RNA hy-                  KREPA3 responsible central catalytic steps <br /> brids, single-stranded RNA, protein (22). binding             editing, affect steps indirectly modes differ ligands (7, 31, 61). Binding C2H2           editosome structure.  KREPA3 appears function ZFs DNA sequence specific binding RNA                RNA binding editosome organization, coordi- <br /> shows enormous diversity sequence specific          nate steps editing affect processivity ZFs typically function form homo- heterodimers          editing. proteins. ZFs KREPA1, KREPA2, KREPA3 widely separated                                         MATERIALS METHODS <br /> amino acids, atypical C2H2 ZFs.                                                                          Plasmid constructs. plasmid expressing tetracycline (tet)-inducible RNAi C-terminal ZF KREPA1  additional                 KREPA3 constructed according report Brecht et al. (8). 701-bp <br /> amino acids second cysteine histi-          fragment 3&#226;&#172;&#732; end KREPA3 amplified using primers 5&#226;&#172;&#732;- <br /> dine), ZFs share (F/T)XCX2CX3FX5&#226;&#338;&#191;X2HX4H                     ATACTCGAGCTGCTGCTAATTCTGC-3&#226;&#172;&#732; 5&#226;&#172;&#732;-ATAAAGCTTTCACACCT <br /> pattern ZF proteins roles       TCAACACTG-3&#226;&#172;&#732;, digested XhoI HindIII, inserted similarly <br />                                                                       digested pZJM (59) create pZJM-A3. restriction sites underlined. DNA, RNA, protein binding. ZFs Trypanosoma              plasmids used generating regulatable knockout (RKO) cell line, BF <br /> brucei KREPA1, KREPA2, KREPA3,                     KREPA3-RKO, based previous strategy (48, 60) modifications. <br /> KREPA2 ortholog Leishmania tarentolae, LC-4,             Distal 5&#226;&#172;&#732; 3&#226;&#172;&#732; KREPA3 open reading frame (ORF) flanking sequences located <br /> proposed act protein-protein interaction substrate           outside flanking sequences used pLEW90-A3-KO2   amplified <br />                                                                       T. brucei 427 genomic DNA using primers 5&#226;&#172;&#732;-ATAGCGGCCGCGCA <br /> RNA recognition binding (25). <br />                                                                       CACGTGTGGACATTATC-3&#226;&#172;&#732; 5&#226;&#172;&#732;-ATAACGCGTCTCGAGAACTTATGG <br />    Different OB-fold domains little sequence similarity      GGTAGAAGACG-3&#226;&#172;&#732; primers 5&#226;&#172;&#732;-ATATCTAGAATTTAAATACCAAG <br /> share conserved topological architecture consisting         CGAGAAAGGGAAGA-3&#226;&#172;&#732; 5&#226;&#172;&#732;- ATAAGGCCTGCGGCCGCTAATGCTGT <br /> &#226;?&#164;-strands forming antiparallel &#226;?&#164;-sheets support com-       TATGGGCGCTG-3&#226;&#172;&#732;, respectively. PCR products digested NotI mon binding face ligands, includes nucleic acids,   MluI XbaI StuI, respectively, inserted similarly digested <br />                                                                       pLEW13 generate construct pLEW13-A3-KO1 replacement oligosaccharides, proteins (1, 35, 55). loops       KREPA3 allele. 5&#226;&#172;&#732; 3&#226;&#172;&#732; flanking sequences adjacent KREPA3 ORF <br /> necting &#226;?&#164;-strands vary widely length conformation      amplified genomic DNA using primers 5&#226;&#172;&#732;-ATAGCGGCCGCTT <br /> accommodate various modes binding different ligands.        GGCGGAAGAAAGAGAACG-3&#226;&#172;&#732; 5&#226;&#172;&#732;-ATAACGCGTCTCGAGGGACGAG C-terminal regions KREPA1, KREPA2, KREPA3,                 ACATGAGGTGATG-3&#226;&#172;&#732; primers 5&#226;&#172;&#732;-ATATCTAGAATTTAAATTGGTG <br />                                                                       CCTCAATATGATGGT-3&#226;&#172;&#732; 5&#226;&#172;&#732;-ATAAGGCCTGCGGCCGCTTGGGACCC <br /> KREPA6 predicted OB-fold domains based                                                                       ATCGCTATTTG-3&#226;&#172;&#732;, respectively. PCR products digested NotI structural organization key types amino acids,         MluI XbaI StuI, respectively, inserted similarly digested <br /> OB-fold KREPA4 similar S1-motif (46).            pLEW13 generate construct pLEW13-A3-KO2. XhoI-EcoRV fragment <br /> OB-fold domains KREPA1 KREPA2 proposed               pLEW13-A3-KO2 replaced XhoI-StuI fragment play roles substrate RNA recognition binding        pLEW90 generate pLEW90-A3-KO2 replacement second KREPA3 <br />                                                                       allele. length KREPA3 ORF amplified genomic DNA using <br /> coordination TUTase ligase, exoUase ligase          primers 5&#226;&#172;&#732;-CCTCGAGCCACCATGAAGCGTGTTACTTCAC-3&#226;&#172;&#732; 5&#226;&#172;&#732;- CG <br /> enzymatic steps editing, respectively (47). KREPA4        GATCCTTATCACACCTTCAACACTGACC-3&#226;&#172;&#732; cloned pLEW79 KREPA6 display RNA-binding activity preference         digestion XhoI BamHI generate pLEW79-KREPA3. <br />  VOL. 28, 2008                                                     KREPA3 ZFs OB-FOLD ESSENTIAL RNA EDITING                                           6941 <br />  <br />    generate KREPA3 mutants tandem affinity purification (TAP) tag      min, followed 40 cycles 95&#194;&#176;C 15 s 60&#194;&#176;C 1 min, using ABI C terminus, length KREPA3 KREPA3 deletion C-             Prism 7000 thermocycler. Relative changes target amplicons determined <br /> terminal OB-fold domain amplified using primers 5&#226;&#172;&#732;-CCTCGAGC             comparing level KREPA3-repressed cells cells CACCATGAAGCGTGTTACTTCAC-3&#226;&#172;&#732; 5&#226;&#172;&#732;- CGGATCCCACCTTCAAC                                KREPA3 expressed normalization 18S rRNA &#226;?&#164;-tubulin using <br /> ACTGACC-3&#226;&#172;&#732; primers 5&#226;&#172;&#732;-CCTCGAGCCACCATGAAGCGTGTTAC                            Pfaffl method (43), PCR efficiencies calculated linear regression using <br /> TTCAC-3&#226;&#172;&#732; 5&#226;&#172;&#732;-CGGATCCCCAATGTGCAGCCACTTC-3&#226;&#172;&#732;, respectively.                         LinregPCR (44). digestion XhoI BamHI, products cloned pLEW79-             Crude mitochondria preparation glycerol gradient sedimentation. Crude <br /> MHTAP (23, 40) create pLEW79-A3-TAP pLEW79-A3&#226;&#338;&#172;OB-TAP. Mu-                    mitochondria prepared roughly 2 &#226;&#171;&#187; 1010 PF KREPA3-RNAi cells tagenesis ZF cysteines alanines performed using QuikChange       3 &#226;&#171;&#187; 109 BF KREPA3-RKO RKO KREPA3 WT-TAP ZFm2-TAP cells II XL site-directed mutagenesis kit (Stratagene, CA). Mutation ZF      absence presence 1 &#226;?&#174;g tet/ml essentially described previously (18). <br /> (C53A/C56A) performed oligonucleotides 5&#226;&#172;&#732;-CACTCCCTCCTTT                mitochondria PFs lysed 1.5 ml mt lysis buffer (20 mM <br /> CAGGCCGGCGAAGCCGGTAAGGCTTTTCGTC-3&#226;&#172;&#732; 5&#226;&#172;&#732;-GACGAAAA                                  HEPES [pH 7.9], 10 mM magnesium acetate, 100 mM KCl, 1 mM EDTA) <br /> GCCTTACCGGCTTCGCCGGCCTGAAAGGAGGGAGTG-3&#226;&#172;&#732;, mutation                                containing protease inhibitors centrifuged twice 13,000 rpm 10 min second ZF (C183A/C186A) performed oligonucleotides 5&#226;&#172;&#732;-G            4&#194;&#176;C. cleared lysates loaded 11-ml 10 30% glycerol gradients GACAAAAAAACATTTGTCGCGACGATTGCTCAGAAAACATTTCG                                        centrifuged 38,000 rpm 12 h 4&#194;&#176;C using SW40 rotor (Beckman). <br /> G-3&#226;&#172;&#732; 5&#226;&#172;&#732;-CCGAAATGTTTTCTGAGCAATCGTCGCGACAAATGTTTTT                                500-&#226;?&#174;l fractions collected  crude <br /> TTGTCC-3&#226;&#172;&#732;, resulting plasmids named pLEW79-A3ZFm1-TAP                   mitochondria BFs lysed 600 &#226;?&#174;l mt lysis buffer, cleared <br /> pLEW79-A3ZFm2-TAP. generate pLEW79-A3ZFm1<span id='am-8' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-9' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span>amp</span>;2-TAP, HindIII                       lysates loaded 4.5-ml glycerol gradients centrifuged 44,000 rpm BamHI fragment containing ZFm2 excised pLEW79-                     9 h 4&#194;&#176;C using SW55 rotor (Beckman). fractions A3ZFm2-TAP inserted pLEW79-A3ZFm1-TAP digested               collected  fractions flash frozen liquid <br /> enzymes. mutations confirmed sequencing. generate             nitrogen stored &#226;&#171;&#186;80&#194;&#176;C Western blotting vitro enzymatic assays. <br /> KREPA3-RKO cell lines constitutively expressed TAP-tagged WT mu-               vitro RNA editing assays. standard vitro RNA editing activities assay <br /> tant KREPA3 alleles, TAP-tagged KREPA3 WT mutant genes                 described previously. Briefly, 5&#226;&#172;&#732;CL18 3&#226;&#172;&#732;CL13pp gPCA6-2A <br /> amplified plasmids described using primers 5&#226;&#172;&#732;-CCTCGA          RNAs used precleaved insertion editing assay specifying insertion <br /> GCCACCATGAAGCGTGTTACTTCAC-3&#226;&#172;&#732; 5&#226;&#172;&#732;-ATTCATGATCAGGTT                                 U&#226;&#8364;&#8482;s, U5 5&#226;&#172;&#732;CL U5 3&#226;&#172;&#732;CL gA6[14]PC-del RNAs used GACTTCCCCGCGGAATTC-3&#226;&#172;&#732;, digested XhoI BclI, inserted                    precleaved deletion editing specifying removal U&#226;&#8364;&#8482;s (20, 21). 5&#226;&#172;&#732;CL18 individually pHD1344tub (10), targets integration constitutively      U5 5&#226;&#172;&#732;CL 5&#226;&#172;&#732; labeled [&#226;?&#165;-32P]<span id='am-15' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-16' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>ATP</span> T4 kinase. A6short/TAG.1 pre- <br /> expressed ectopic alleles &#226;?&#164;-tubulin locus.                                     mRNA D34 gRNA RNA substrates deletion site cleavage assays, <br />    Transfections repression KREPA3 expression. T. brucei PF 29-13        A6-eES1 pre-mRNA gA6[14] gRNA RNA substrates insertion <br /> cell line (60) transfected 10 &#226;?&#174;g NotI-linearized pZJM-A3, stable    site cleavage assays (10, 13, 24, 49). A6short/TAG.1 A6-eES1 mRNAs transfectants screened described previously (59). resulting cell line   3&#226;&#172;&#732; labeled 32P-labeled pCp T4 RNA ligase. Portions (10 &#226;?&#174;l) indi- named PF KREPA3-RNAi maintained SDM-79 medium plus 10%                   vidual pooled gradient fractions TEV eluates purification immu- <br /> fetal bovine serum 15 &#226;?&#174;g G418/ml, 25 &#226;?&#174;g hygromycin/ml, 2.5 &#226;?&#174;g        noglobulin G (IgG) beads incubated different substrate RNAs phleomycin/ml. dsRNA induced adding 1 &#226;?&#174;g tet/ml. Growth         enzymatic reactions. reaction products resolved 7 M <span id='am-46' about='obo:IMR_0200111' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-47' property="oboInOwl:id" content="IMR:0200111" datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="Urea" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasDbXref" content="KEGG:C00086" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>urea</span>-poly- <br /> cells monitored absence presence tet counted daily      acrylamide gels visualized Storm PhosphorImager screens (Molecular Coulter counter. cells maintained 1.0 &#226;&#171;&#187; 106 2.0 &#226;&#171;&#187;       Dynamics). <br /> 107 cells/ml.                                                                          RNA ligase adenylation assays performed follows. mt gradient frac- <br />    BF KREPA3-RKO cell line generated previously described (48,           tions (5 &#226;?&#174;l) incubated 5 &#226;?&#174;Ci [&#226;?&#163;-32P]ATP 20-&#226;?&#174;l reaction 60) maintained HMI-9 medium plus 10% fetal bovine serum multiple        (12.5 mM KCl, 12.5 mM HEPES [pH 7.9], 5 mM magnesium acetate, 0.25 mM <br /> selection markers  . Briefly, wild-type BF 427 cells electroporated      dithiothreitol) 28&#194;&#176;C 5 min stopped addition 10 &#226;?&#174;l 3&#226;&#171;&#187; NotI-linearized plasmids stepwise order; pLEW13-A3-KO1         sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading selection 2.5 &#226;?&#174;g G418/ml replace KREPA3 alleles,     dye. proteins resolved SDS&#226;&#8364;&#8220;10% PAGE, radiolabeled pLEW79-KREPA3 selection 2.5 &#226;?&#174;g phleomycin/ml insert         proteins detected using PhosphorImager. <br /> tet-regulatable ectopic KREPA3 allele ribosomal DNA spacer region,            Coimmunoprecipitation purification TAP-tagged proteins. mono- finally pLEW90-A3-KO2 selection 5 &#226;?&#174;g hygromycin/ml          clonal antibody (MAb) specific KREPA2 (39) incubated goat <br /> addition 1 &#226;?&#174;g tet/ml induce ectopic KREPA3 expression replace      anti-mouse IgG-conjugated magnetic beads (Dynal) 2 h 4&#194;&#176;C rotation. <br /> second KREPA3 endogenous allele. Correct integration plasmid            crude mt lysates uninduced induced PF KREPA3-RNAi cells confirmed PCR. expression ectopic KREPA3 repressed wash-           lysed IPP200 containing protease inhibitor cocktail 1% Triton X-100 <br /> ing culturing cells medium minus tet. Growth cells        (Roche). cleared lysate incubated KREPA2 MAb coated beads <br /> monitored presence absence tet diluted daily 1.0 &#226;&#171;&#187; 105       2 h 4&#194;&#176;C rotation. beads washed IPP200 times, 2.0 &#226;&#171;&#187; 105 cells/ml.                                                                 1&#226;&#171;&#187; SDS loading buffer added boiled 5 min. starting lysate,    pHD1344tub plasmids TAP-tagged WT mutant KREPA3 genes                supernatant immunoprecipitation, precipitates resolved constitutive expression tubulin locus linearized NotI    SDS&#226;&#8364;&#8220;10% PAGE, Western blot performed specific MAbs <br /> transfected KREPA3-RKO cells independently. resistant clones          KREPA1, KREPA2, KREPA3, KREL1 (39). <br /> selected 0.1 &#226;?&#174;g puromycin/ml designated RKO-KREPA3 WT-TAP,                 BF KREPA3-RKO tagged RKO-KREPA3 WT mutant cells (2 &#226;&#171;&#187; 108) <br /> ZFm1-TAP, ZFm2-TAP, ZFm1&amp;2-TAP, &#226;&#338;&#172;OB-TAP. Expression                      grown presence absence tet 3 days harvested lysed tagged genes determined Western blotting.                                    IPP150 containing cocktail protease inhibitors (Roche) plus 1% Triton <br />    RNA isolation real-time RT-PCR analysis. Total RNA harvested             X-100. cell lysates incubated IgG-conjugated agarose beads cell lines using TRIzol LS reagent (Gibco-BRL) according        2 h cleaved TEV protease 2 h 16&#194;&#176;C. starting cell <br /> manufacturer&#226;&#8364;&#8482;s instructions. Real-time reverse transcription-PCR (RT-PCR)           lysates TEV eluates resolved SDS&#226;&#8364;&#8220;10% PAGE assayed performed described previously (9). Briefly, 10 &#226;?&#174;g RNA treated        Western blotting MAbs KREPA1, KREPA2, KREPA3, KREL1 DNase using DNA-free kit (Ambion).  4.5 &#226;?&#174;g treated          polyclonal antibodies KREPA6 (47) PGK (41), level PGK <br /> RNA reverse transcribed using random hexamers TaqMan RT                  control. Portions (10 &#226;?&#174;l) TEV eluates used reagents (Applied Biosystems) generate cDNA templates real-time          vitro RNA editing assay. <br /> PCR. time, control reaction reverse transcriptase carried rule contamination genomic DNA. cDNA reactions diluted 1:7 water template PCRs diluted 1:50 <br />                                                                                                                       RESULTS PCR high abundance internal control 18S rRNA &#226;?&#164;-tubulin. PCR included 2.5 &#226;?&#174;l cDNA, 10 &#226;?&#174;l forward reverse primers  0.75       KREPA3 essential growth vivo RNA editing. <br /> &#226;?&#174;M), 12.5 &#226;?&#174;l Sybr green PCR master mix (Applied Biosystems) mixed 96 plate (Applied Biosystems), kind mRNA                                                                                     effect KREPA3 repression cell growth examined <br /> analyzed triplicate. sequences used primers        PF BF stages T. brucei. Expression scribed (9). amplification conditions 50&#194;&#176;C 2 min 95&#194;&#176;C 10       KREPA3 repressed PFs generating RNAi cell line <br />  6942     GUO ET AL.                                                                                                           MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 2. KREPA3 repression essential growth vivo RNA editing BFs PFs. Growth PF KREPA3-RNAi   BF <br /> KREPA3-RKO (B) cells KREPA3 expressed repressed. KREPA3 expression repressed addition tet PFs induce <br /> RNAi expression withdrawal tet BFs repress KREPA3 transcription. insets Western analysis lysates PF cells day 6 BF cells day 4 using KREPA3 MAb. positive controls pooled 20S fractions glycerol gradient purified mt lysate WT PF mitochondria panel BF cell lysate panel B. (C D) relative abundance pre-edited, edited, edited ND4 COI mRNAs cells KREPA3 repressed compared cells expressed PF KREPA3-RNAi cells day 6 (C) BF KREPA3-RKO cells day 4 (D). relative change target amplicon determined real-time RT-PCR total RNA normalized &#226;?&#164;-tubulin 18S rRNA. Note log scale 1 represents difference, &#226;&#172;&#381;1 increase, &#226;&#172;?1 decrease. <br />  <br />  <br />  29-13 PFs (PF KREPA3-RNAi) expresses dsRNA                   pressed PF BF control cells grew normal rate. <br /> portion KREPA3 mRNA control tet-inducible                 KREPA3 protein detected PFs BFs 6 4 <br /> promoter previously described (8). Expression KREPA3                days repression, respectively, (insets, Fig. 2A B) blocked BFs generating regulatable knockout cell              determined Western analysis KREPA3 MAb. line (BF KREPA3-RKO) disrupting endogenous al-                    motile PF RNAi cells seen microscope 12 days leles homologous recombination inserting tet-regu-               RNAi induction tet, cell debris seen 6 days <br /> latable ectopic KREPA3 allele (KREPA3 Reg) ribo-                 repression BF RKO cells tet withdrawal. somal DNA locus described Materials Methods. Cell               motile PF cells BF cells indicate complete <br /> growth inhibited dramatically KREPA3 repression                  KREPA3 repression RNAi compared conditional tet-induced RNAi PFs (Fig. 2A) completely blocked               knockout, commonly observed, reflect BFs withdrawal tet (Fig. 2B), nonre-               slower growth rate PFs, differences life <br />  VOL. 28, 2008                                            KREPA3 ZFs OB-FOLD ESSENTIAL RNA EDITING                           6943 <br />  <br />  <br /> cycles stages, combination thereof. Real-time PCR                KREPA3 repression, seen using cocktail analysis total RNA cells showed mRNA                MAbs auto-adenylation KREL1 KREL2 (Fig. <br /> levels KREPA1, KREPA2, KREPA5, KREPA6                        3B). KREPA1 adenylatable KREL1 KREL2 shifted <br /> editosome proteins, related KREPA3,                 smaller S region gradient KREPA3 repression <br /> affected KREPA3 repression RNAi induction RKO                   did KREPA2 KREL1 proteins seen Western <br /> (data shown), indicating repression specific         analysis (Fig. 3B).  subcomplex containing KREPA1 <br /> KREPA3. Overall, dramatic repression growth               KREL2 fewer components PFs BFs repression KREPA3 expression indicates                 KREPA2 KREL1. peak KREL1 protein protein essential life cycle stages T. brucei.   greater S value region gradient seen Western <br />    effect KREPA3 repression RNA editing vivo                blotting autoadenylation, implying adenylated assessed PF BF stages real-time PCR. Total            primed ligate RNA. editosomes remain RNA isolated nonrepressed PF KREPA3-RNAi                     &#226;&#172;&#402;20 40S region following KREPA3 repression despite <br /> BF KREPA3-RKO cells, cells 6              extensive loss KREPA3. reflect  <br /> 4 days repression KREPA3 expression, respectively,            complete elimination KREPA3 faint signal growth inhibition manifested. levels edited           KREPA3 detected region longer exposures <br /> pre-edited mRNAs ND9, edited                 presence editosomes lack protein.  <br /> ND4 COI mRNAs, determined normalized                      data indicate KREPA3 required editosome &#226;?&#164;-tubulin mRNA 18S rRNA internal controls.                   integrity critical bridge interaction inser- <br /> levels ND4 COI mRNAs repressed cells relative              tion deletion subcomplexes, insertion subcom- nonrepressed cells unaffected,              plexes failed associate deletion subcomplexes. <br /> levels pre-edited mRNAs unchanged increased                   KREPA3 repression resulted shift vitro <br /> various amounts (Fig. 2C D). contrast, relative               precleaved U-insertion/ligation U-deletion/ligation activi- <br /> levels edited mRNAs reduced dramatically PF              ties smaller S value gradients, fraction 15-23 BF cells KREPA3 repression. 2 11                fraction 11-17 (Fig. 3C D), corresponding shift edited mRNAs tested reduced 90% (Fig. 2C                editosome proteins. KREPA3 repression did result D). level edited CYb mRNA detection                  obvious reduction U-insertion U-deletion activities. <br /> BFs (data shown). edited mRNAs                    TUTase exoUase activities somewhat <br /> duced BFs PFs, especially evident COII               affected ligated products U added (Fig. 3C) mRNA, lower efficiency KREPA3 repres-                U&#226;&#8364;&#8482;s removed (Fig. 3D) enhanced KREPA3 <br /> sion RNAi compared regulatable double knockout.                repression, possibly alterations editosome integ- lack concomitant increase levels pre-            rity. contrast precleaved editing activities, inser- <br /> mRNAs dramatic reduction edited RNA                    tion deletion site endonuclease activities remained &#226;&#172;&#402;20 <br /> reflect inherent differential turnover rates RNAs.          40S reduced KREPA3 repression  KREPA3 essential RNA editing vivo PFs            compared control cells (Fig. 3E F). BFs. extensive reduction edited mRNA                     remaining endonuclease activities correlates residual <br /> KREPA3 knockdown suggests structurally                  level editosomes KREPA3 level necessary editosome integrity play critical             determined phosphorimager quantitation (data shown). <br /> roles RNA editing process vivo.                                 reduction endonuclease activities appears    KREPA3 repression PFs affects editosome stability              editosome disruption loss KREPA3. vitro editing. effect KREPA3 repression PFs              Overall, data indicate repression KREPA3 ex- <br /> editosome stability integrity examined coimmuno-              pression affected vitro editing activities precipitation sedimentation glycerol gradients. Lysates           effect mainly attributable altered editosome structure. PF KREPA3-RNAi cells KREPA3                        differs conclusions Brecht et al. (8) dis- <br /> expressed repressed incubated KREPA2 MAb                  cussed  &#226;&#172;&#402;20S editosomes retained PF cells bound IgG-coated magnetic beads. supernatants                 KREPA3 repression competent vitro RNA ed- <br /> immunoprecipitates examined Western analysis using               iting activities insufficient support cell growth mixture MAbs specific KREPA1, KREPA2, KREL1,                    vivo editing. KREPA3 (Fig. 3A). repression KREPA3                     Editosome loss KREPA3 repression BFs. Repres- <br /> inhibited significantly 6 days RNAi induction,        sion KREPA3 expression BF KREPA3-RKO cells  <br /> editosome proteins evident total lysate (input).         sulted dramatic loss editosomes vitro editing <br /> loading control shown. KREPA2 KREL1                 activities (Fig. 4) contrast partial effect observed PF <br /> immunoprecipitated lysates KREPA3 ex-                KREPA3-RNAi cells. Western analysis crude mt lysates <br /> pression repressed, KREPA1 remained                  antibody cocktail editosome proteins <br /> supernatant KREPA3 repressed. consistent                showed proteins lost BF KREPA3-RKO previous findings KREL1 interacts KREPA2                  cells 4 days repression KREPA3 expression (Fig. occurs deletion subcomplex, KREX2,             4A). MAb66 used detect 3-methylcrotonoyl-coen- <br /> KREPA1, KREL2, KRET2 occur insertion subcom-                   zyme carboxylase &#226;?&#164; protein   Panigrahi, unpublished <br /> plex (47). Glycerol gradient sedimentation cleared crude mt           data), relationship RNA editing, used <br /> lysates cells revealed shift peak             loading control. weak signal discernible editosome components &#226;&#172;&#402;20S smaller S region                KREPA2 region blot KREPA3 repression BFs, <br />  6944      GUO ET AL.                                                                                                                MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />   FIG. 3. Disruption editosomes effect vitro RNA editing activities KREPA3 repression RNAi PFs.   Western analysis crude mt lysates PF KREPA3-RNAi cells KREPA3 expressed repressed 6 days (input) immunoprecipitation KREPA2 MAb. Western used mixture MAbs editosome components indicated right. Note presence KREPA2 KREL1 precipitate. 20S positive control described Fig. 2A. (B) Western adenylation analyses glycerol gradient fractions crude mt lysates cells panel  Western blot analyses used mixture MAbs indicated, adenylation assays reveal KREL1 KREL2. fractions used vitro precleaved insertion (C) precleaved deletion (D) assays endonuclease assays specific A6 insertion (E) deletion (F) sites. RNA substrates described Materials Methods. radiolabeled input RNAs  , input RNA U&#226;&#8364;&#8482;s added (&#226;&#171;&#185;2U), U&#226;&#8364;&#8482;s removed (&#226;&#171;&#186;4U), ligated products unprocessed 5&#226;&#172;&#732; 3&#226;&#172;&#732; input RNAs (Lig) edited (Ed) products indicated. position specific, gRNA-directed cleavage products indicated arrow. gRNA omitted control reactions (g-) RNase <br /> T1-digested substrate RNA (T1) used marker. Positive control reactions (&#226;&#171;&#185;) performed using fraction &#226;&#172;&#402;20S editosome contains <br /> peak editing activity, omitted negative control reactions (&#226;&#171;&#186;). <br />  VOL. 28, 2008                                            KREPA3 ZFs OB-FOLD ESSENTIAL RNA EDITING                               6945 <br />  <br />  <br />  <br />  <br />    FIG. 4. KREPA3 repression BFs conditional knockout results loss editosome vitro RNA editing activities.   Different <br /> effect KREPA3 repression editosome BFs compared PFs. Western analysis crude mt lysates BF KREPA3-RKO (left panel) PF KREPA3-RNAi (right panel) cells KREPA3 expressed repressed 4 6 days, respectively, using cocktail MAbs indicated. 20S positive control described Fig. 2A, MAb66 used loading control. (B) Effect KREPA3 repression BF KREPA3-RKO cells editosome sedimentation. Western analysis glycerol gradient fractions crude mt lysates BF KREPA3-RKO <br /> cells KREPA3 expressed repressed 2 4 days using cocktail MAbs indicated. 20S positive control Fig. <br /> 2B MAb66 used control. peak editosome fractions 19 23 (&#226;&#172;&#402;20 40S region) pooled used vitro precleaved <br /> insertion (C) precleaved deletion (D) assays endonuclease assays specific A6 insertion (E) deletion (F) sites. Assay designations Fig. 3. <br />  <br />  <br />  <br />  KREPA1, KREL1, KREPA3 undetectable (Fig.                      insertion deletion site endonuclease activities pooled <br /> 4A, left panel). contrast essentially unchanged          &#226;&#172;&#402;20 40S fractions dramatically reduced 2 days <br /> levels KREPA1, KREPA2, KREL1 proteins                          undetectable 4 days KREPA3 repression, finding <br /> KREPA3 repression RNAi PFs (Fig. 4A, right panel).                concordant loss editosomes (Fig. 4C, D, E, F). likely difference editosome pro-               KREPA3 structurally necessary editosome <br /> teins remaining KREPA3 repression differ-              stability integrity BFs loss KREPA3 results ent methods used repress KREPA3 expression dif-                  complete loss editosomes, components, vitro <br /> ferences editosomes life cycle stages.                editing activities. <br /> Glycerol gradient sedimentation analysis cleared crude mt                  ZF mutation OB-fold deletion KREPA3 lethal lysates BF KREPA3-RKO cells KREPA3                       blocks editing vivo. KREPA3 ZF motifs OB-fold expressed repressed 2 4 days revealed dramatic             domain critical KREPA3 function loss editosomes. tested editosome components                        vivo. effects mutating ZFs deleting (KREPA1, KREPA2, KREL1, KREPA6) substantially                       OB-fold domain cell growth examined generat- <br /> creased &#226;&#172;&#402;20 40S region 2 days KREPA3                    ing transgenic BF cells exclusively express mutant <br /> repression small amounts components seen              KREPA3 proteins. mutations replaced cysteines upper fractions (Fig. 4B, middle panel). editosome proteins             alanines C2H2 ZF motifs deleted OB-fold detected &#226;&#172;&#402;20S 40S region 4 days                    domain diagrammed Fig. 5A. WT mutant KREPA3 <br /> KREPA3 repression small amounts KREPA1                     alleles inserted &#226;?&#164;-tubulin locus BF KREPA3- <br /> KREPA2 gradient fractions (Fig. 4B,                  RKO cells, constitutively expressed. alleles <br /> lower panel). surprisingly, precleaved insertion (TUTase           TAP-tagged discriminate tet-regulated ligase), precleaved deletion (ExoUase ligase),             WT KREPA3 allele, KREPA3 Reg, rRNA locus  6946     GUO ET AL.                                                                                                     MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 5. Mutation ZFs deletion OB-fold KREPA3 results cell death loss vivo RNA editing.   Schematic <br /> representation WT mutant TAP-tagged KREPA3. cysteines ZFs mutated alanines resulting ZFm1-TAP (C53A/C56A), ZFm2-TAP (C183A/C186A), ZFm1&amp;2-TAP (C53A/C56A/C183A/C186A) truncation KREPA3 OB-fold named &#226;&#338;&#172;OB-TAP. (B) Cell growth presence constitutively expressed WT mutant TAP-tagged KREPA3 KREPA3 Reg expressed (E) repressed (R). Constitutively expressed WT mutant TAP-tagged KREPA3 alleles integrated &#226;?&#164;-tubulin locus BF KREPA3-RKO cells, expression KREPA3 Reg controlled adding withdrawing <br /> tet. (C) Western analysis KREPA3 Reg TAP-tagged KREPA3 allele expression using KREPA3 MAb. KREPA3 Reg expression efficiently repressed withdrawal tet 3 days. (D) relative abundance pre-edited, edited, edited mRNAs cells <br /> exclusively expressing WT mutant TAP-tagged KREPA3 alleles KREPA3 Reg repressed 3 days compared cells expressed detected real-time RT-PCR. relative change amplicons pre-edited edited A6, COIII, COII edited ND4 normalized 18S rRNA. Note log scale 1 represents difference, &#226;&#172;&#381;1 increase, &#226;&#172;?1 decrease. <br />  VOL. 28, 2008                                          KREPA3 ZFs OB-FOLD ESSENTIAL RNA EDITING                        6947 <br />  <br />  <br /> allow purification proteins. resulting cells      formed gradient fractions using panel editosome <br /> designated RKO-KREPA3WT-TAP, RKO-KREPA3ZFm1-TAP,                      MAbs similarly treated lysates KREPA3-RKO cells RKO-KREPA3ZFm2-TAP, RKO-KREPA3ZFm1&amp;2-TAP,                         absence KREPA3 Reg expression serving control. RKO-KREPA3&#226;&#338;&#172;OB-TAP. cells grew rate             portion KREPA3 WT-TAP ZFm2-TAP proteins presence tet, e., KREPA3 Reg expressed.          incorporate &#226;&#172;&#402;20-40S complexes, Withdrawal tet resulted cessation cell growth      KREPA1 KREL1 editosome components 4 days KREPA3 mutants (Fig. 5B). live cells,        KREPA3 Reg repressed, contrast virtual lack cell debris, observed day 6, finding           editosome proteins region control cells (Fig. <br /> similar consequence repression KREPA3 expres-            6A).  tagged WT ZFm2 proteins able <br /> sion BF KREPA3-RKO cells. Growth RKO-KREPA3                     restore presence &#226;&#172;&#402;20S editosomes. WT-TAP cells inhibited extent KREPA3                 tagged WT KREPA3 sedimented &#226;&#172;&#402;5 10S region Reg repression, cells continued slower growth rate         KREPA3 Reg expressed, shifted ultimate death (Fig. 5B). presumably           larger S values expression untagged KREPA3 <br /> effect TAP tag expression KREPA3 Reg              eliminated, e., KREPA3 Reg repressed 3 days. tag supported cell growth normal rate (Fig.          levels KREPA1 KREL1 lower 2B). Western analysis KREPA3 MAb revealed               cells exclusively expressing WT-TAP protein cells withdrawal tet essentially eliminated expression        expressing untagged KREPA3 Reg (Fig. 6A).  <br /> KREPA3 Reg allele 3 days (Fig. 5C). revealed       C-terminal tag hampered ability protein effi- level TAP-tagged KREPA3ZFm1 ZFm1&amp;2                     ciently remain incorporated &#226;&#172;&#402;20S editosomes, untagged <br /> proteins lower levels WT ZFm2 pro-            KREPA3 appears compete tagged version  <br /> teins similar numbers cells. result observed       corporation 20S editosomes. consistent using PAP reagent specific protein com-         partial inhibition cell growth vivo editing RKO <br /> ponent TAP tag (data shown), indicated          WT-TAP cells absence KREPA3 Reg expression. ZF mutation effect recognition KREPA3             Parallel studies revealed tagged KREPA3 ZFm2 pro- MAb.  ZFs OB-fold domain               tein primarily located smaller S value region necessary KREPA3 function vivo, mutations         gradient WT-TAP KREPA3 Reg expressed motifs lethal, similar effect KREPA3           did shift larger S region KREPA3 Reg expression <br /> pression BF KREPA3-RKO cells.                                      repressed (Fig. 6A).  KREL1 shifted smaller S <br />    Exclusive expression ZF mutation OB-fold         value region gradient repression KREPA3 Reg <br /> letion (&#226;&#338;&#172;OB) KREPA3 abolished editing vivo extent         expression, case WT tagged KREPA3 <br /> similar loss KREPA3 expression, revealed real-        (Fig. 6A). Considering expression ZFm2-TAP com- <br /> time PCR. Total RNA isolated parental BF                 pletely blocked growth vivo editing, result suggests <br /> KREPA3-RKO cells BF KREPA3-RKO cells expressing               ZFm2 protein involved protein RNA <br /> TAP-tagged KREPA3 WT, ZFm2 &#226;&#338;&#172;OB mutant alleles                 interaction fashion affects editosome integrity, KREPA3 Reg expression repression 3 days. abun-             vivo function, different WT version. <br /> dance pre-edited edited A6, COIII, COII             effect tag mutations ZFs edited ND4 mRNAs assayed real-time PCR,                association KREPA3 editosome components <br /> relative mRNAs levels normalized 18S rRNA            presence absence untagged WT protein ex- <br /> ternal control (Fig. 5D). relative mRNA abundance        plored purification tagged complexes. normalized &#226;?&#164;-tubulin results (data shown).       tagged complexes immunoprecipitated IgG beads <br /> Repression KREPA3 Reg expression results exclusive        KREPA3-RKO derivative cells expressing TAP- <br /> expression TAP-tagged KREPA3ZFm2 KREPA3&#226;&#338;&#172;OB es-                  tagged KREPA3 WT ZF mutant proteins KREPA3 <br /> sentially abolished vivo editing. relative abundance        Reg expressed repressed 3 days. complexes edited mRNA decreased level parental       eluted TEV protease cleavage, eluates starting <br /> BF KREPA3-RKO cells absence KREPA3 Reg expres-              cell lysates analyzed Western analysis sion, e., ca. 95 99%, pre-edited mRNA levels        panel editosome MAbs. studies clearly showed unchanged slightly increased (Fig. 5D). Exclusive expres-     tagged WT protein did associate editosomes sion TAP-tagged WT KREPA3 protein, somewhat              cells expressing KREPA3 Reg did KREPA3 Reg <br /> inhibited growth, resulted 30 60% inhibition vivo       expression repressed, expressed similar <br /> editing (Fig. 5D). cases, relative abundance   levels shown Western analysis cell lysates (Fig. edited ND4 mRNA essentially unchanged.           7A). consistent sedimentation results Fig. <br /> data indicate ZF motifs OB-fold domain neces-        6A. Compared WT-TAP cells KREPA3 Reg  <br /> sary KREPA3 function RNA editing vivo.                 pressed, similar amounts tested editosome components <br />    C-terminal TAP tag ZF mutations affect KREPA3              coprecipitated tagged KREPA3 proteins editosome association. effect mutation second           ZFs mutated, cells expressing KREPA3 Reg <br /> ZF association KREPA3 editosome          (Fig. 6A), indicated ZF disruption little effect <br /> estimated editosome sedimentation. Crude mt lysates           KREPA3-mediated protein interactions. results RKO-KREPA3 WT-TAP ZFm2-TAP cells presence                   suggested association editosome WT versus absence KREPA3 Reg expression subjected                 ZF mutants different protein RNA. Extra <br /> glycerol gradient sedimentation. Western analysis             bands observed TEV eluates probed  6948      GUO ET AL.                                                                                                        MOL. CELL. BIOL. <br />  <br />  <br />                                                                            required protein interactions editosome, suggest- <br />                                                                            ing ZFs function RNA binding RNA pro- <br />                                                                            cessing.  exclude possibility ZFs <br />                                                                            involved unknown protein interactions                                                                            conformation entire editosome. <br />                                                                               Analysis glycerol gradient fractions containing primarily <br />                                                                            TAP-tagged KREPA3 (Fig. 6A B) showed                                                                            KREPA3 does editing enzymatic activities.                                                                            &#226;&#172;&#402;5 10S &#226;&#172;&#402;20 40S gradient fractions                                                                            RKO-KREPA3 WT-TAP cells KREPA3 Reg expression <br />                                                                            repressed (Fig. 6A) pooled subjected Western <br />                                                                            analysis vitro editing assays (Fig. 6B). Western analysis <br />                                                                            showed tagged protein abundant protein <br />                                                                            detected &#226;&#172;&#402;5 10S fractions, &#226;&#172;&#402;20 40S <br />                                                                            fractions contained KREPA1 KREL1. Virtually                                                                            specific editing enzymatic activities detected                                                                            pooled &#226;&#172;&#402;5 10S fractions containing WT KREPA3-TAP <br />                                                                            protein. U-removal products &#226;&#172;&#402;5 10S fractions                                                                            probably nonspecific cleavage nucleases <br />                                                                            detected &#226;&#172;&#402;5 10S fractions                                                                            KREPA3-RKO cells absence KREPA3 Reg expres- <br />                                                                            sion (data shown). expected, pooled &#226;&#172;&#402;20 40S <br />                                                                            fractions exhibited vitro editing activities.  <br />                                                                            KREPA3 does appear catalyze specific enzymatic <br />                                                                            steps editing. <br />                                                                               effects ZF mutation vitro precleaved U-inser- <br />                                                                            tion U-deletion editing (Fig. 7B C) insertion                                                                            deletion site endonuclease cleavage (Fig. 7D E)                                                                            assayed using TEV eluates shown Fig. 7A.                                                                            purified editing complexes enzymatic activities consistent <br />                                                                            level editosome proteins copurified TAP- <br />                                                                            tagged KREPA3 WT ZF mutants. addition, mutation                                                                            KREPA3 ZFs direct effect activities. <br />    FIG. 6. Effect KREPA3 ZF disruption editosome sedimen-            Stronger editing activities observed WT-TAP  <br /> tation.   Western analysis glycerol gradient fractions crude mt    taining complexes KREPA3 Reg repressed lysates BF RKO-KREPA3 WT-TAP ZFm2-TAP cells KREPA3 Reg expressed (E) repressed (R) 3 days. Western <br />                                                                            expressed, incorporation analysis performed antibodies KREPA1, KREL1,          WT-TAP protein editosomes KREPA3 repression <br /> KREPA3. Similarly prepared lysates BF KREPA3-RKO pa-              (Fig. 6A 7A). contrast, TEV eluates cells <br /> rental cells KREPA3 expression repressed 3 days serves     ZF mutants presence KREPA3 Reg expres- <br /> control. Compared control, exclusive expression           sion slightly decreased level U-insertion activity KREPA3 WT-TAP ZFm2-TAP rescued presence &#226;&#172;&#402;20 40S editosomes various amounts.  KREPA3 WT-TAP             KREPA3 Reg repression, corresponded reduc- ZFm2-TAP proteins displayed different distributions glyc-       tion KREPA1 protein (Fig. 7A) representing insertion <br /> erol gradients. (B) Western analysis editing assays pooled      subcomplex. Overall, editosomes rescued tagged <br /> &#226;&#172;&#402;5 10S &#226;&#172;&#402;20 40S gradient fractions WT-TAP               KREPA3 ZF mutants editing activities similar KREPA3 Reg repression panel  Western analysis performed MAb mixture KREPA1, KREPA3, KREL1.                                                                            rescued tagged KREPA3 WT protein, indicating editing assays designations described Fig. 3. substantial   disruption ZFs effect enzymatic activities KREPA3-WT TAP protein pooled &#226;&#172;&#402;5 10S frac-              editing vitro.  KREPA3 ZFs critical tions does catalyze editing activities.                     vitro enzymatic activities protein interactions                                                                            editosome essential survival cells editing <br />                                                                            vivo. <br /> KREPA3 MAb, protease degradation products                      KREPA3 OB-fold deletion abolishes interaction untagged KREA3 Reg (labeled asterisk;                editosome. effect deletion OB-fold KREPA3 <br /> appeared KREPA3 Reg expression, size similar            editosome examined. Tagged KREPA3&#226;&#338;&#172;OB pro- <br /> KREPA3). addition, purification tagged complexes            tein purified lysates BF RKO-KREPA3&#226;&#338;&#172;OB-TAP <br /> RKO WT-TAP ZFm2-TAP cells using TAP procedure                      cells KREPA3 Reg expressed repressed 3 identification proteins liquid chromatography-tan-           days using IgG beads, protein eluted cleavage <br /> dem mass spectrometry (LC-MS/MS) showed                   TEV protease. Western analysis performed editosome proteins copurified KREPA3 ZFm2-TAP                    cell lysates (Fig. 8A) TEV eluates (Fig. 8B) <br /> similar observed WT-TAP (data shown).                 using panel editosome MAbs. KREPA1 KREPA6  data revealed ZFs KREPA3                  detected cell lysates KREPA3&#226;&#338;&#172;OB-TAP <br />  VOL. 28, 2008                                            KREPA3 ZFs OB-FOLD ESSENTIAL RNA EDITING                               6949 <br />  <br />  <br />  <br />  <br />   FIG. 7. Effect KREPA3 ZF disruption interaction editosome editing activities vitro.   Western analysis cell lysates complexes copurified TAP-tagged WT ZF mutant KREPA3 proteins presence absence KREPA3 Reg. Lysates equal <br /> numbers BF KREPA3-RKO, RKO-KREPA3 WT-TAP, ZFm1-TAP, ZFm2-TAP, ZFm1&amp;2 cells KREPA3 Reg expressed (E) repressed (R) 3 days purified IgG beads eluted TEV cleavage. TEV eluates probed antibodies KREPA1, KREPA2, KREPA3, KREL1, KREPA6, cell lysates probed antibodies KREPA3, KREPA6, PGK, serving control. 20S positive control Fig. 2B. Roughly similar amounts editosome proteins purified TAP-tagged KREPA3 ZF mutants KREPA3 expressed  contrast, significant amounts editosome proteins purified WT-TAP protein KREPA3 Reg repressed. TEV eluates used vitro precleaved insertion (B) deletion <br /> (C) assays insertion (D) deletion (E) endonuclease cleavage assays. activity assays designations Fig. 3. tagged <br /> KREPA3 ZF mutant complexes contain vitro editing activities. <br />  <br />  <br />  <br />  <br /> cells following KREPA3 Reg repression TEV eluates                    analysis using MAb cocktail (Fig. 8C). KREPA3&#226;&#338;&#172;OB-TAP KREPA3 Reg expressed (Fig. 8A B).                   sedimented smaller S values editosome, indicating  editosome components purified                   associated editosome KREPA3&#226;&#338;&#172;OB-TAP TEV eluates LC-MS/MS (data                            gradient. suggested KREPA3&#226;&#338;&#172;OB- <br /> shown). addition, crude mt lysate cells             TAP aggregate interact proteins.  ex- <br /> presence KREPA3 Reg expression sedimented glyc-                  clusive expression KREPA3&#226;&#338;&#172;OB incapable erol gradients, fractions subjected Western                rescuing cell death incapable recovering editosomes <br />  6950     GUO ET AL.                                                                                                   MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />   FIG. 8. KREPA3 OB-fold domain necessary editosome integrity. Western analysis purified tagged KREPA3&#226;&#338;&#172;OB protein BF <br /> RKO-KREPA3&#226;&#338;&#172;OB-TAP cells KREPA3 Reg expressed (E) repressed (R) 3 days using IgG beads eluted TEV cleavage.  B) cell lysates   TEV eluates (B) probed panel editing antibodies. KREPA1 KREPA6 undetectable total cell lysates repression KREPA3 Reg expression. PGK used loading control. purification, editosome <br /> components detected TEV eluates. (C) Western analysis gradient fractions crude mt lysates  BF RKO-KREPA3&#226;&#338;&#172;OB-TAP <br /> cells presence KREPA3 Reg expression. Western analysis performed panel editing MAbs. KREPA3&#226;&#338;&#172;OB-TAP did cosediment editosome. <br />  <br />  <br />  <br /> following repression KREPA3 Reg expression. sug-             deletion endonuclease activities.  KREPA3 ZF <br /> gests OB-fold, function <span id='am-26' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-27' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-29' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-31' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span>nucleotide</span> bind-       mutations resulted editosome destabilization subcom- <br /> ing, critical protein interactions editosome.          plexes accumulated mutation ZF2. KREPA3                                                                      lacks OB-fold incorporated editosomes.  <br />                                                                      ZFs essential vivo important editosome <br />                         DISCUSSION <br />                                                                      stability, OB-fold essential vivo critical    KREPA3 essential RNA editing             editosome integrity. editosome integrity (Fig. 3A B) U-              results presented indicate addition, U-removal, RNA ligase catalytic steps editing     KREPA3 affect activity does directly catalyze <br /> T. brucei (Fig. 3C F). RNAi-mediated knockdown                 3&#226;&#172;&#732; TUTase, 3&#226;&#172;&#732; exoUase, ligase steps editing KREPA3 expression inhibited growth PFs, observed           subcomplexes devoid KREPA3 catalyze activities (30). <br /> previously (8, 30), resulted dramatic reduction      unlikely KREPA3 editing endonuclease ac- <br /> abundance edited, pre-edited mRNAs. KREPA3                tivity itself, reports indicate recombinant <br /> knockdown resulted partial disruption 20S editosomes           KREPA3 nuclease activity (8, 36). KREN1, KREN2, insertion deletion subcomplexes vitro         KREN3 endonucleases shown mutation residues U-insertion/ligation U-deletion/ligation activities     RNase III domains block editing vivo elim- separately immunoprecipitated. Editosome endonucle-           inate endonucleolytic cleavage editosomes vitro (10, 11, <br /> ase activities reduced detected 20S edi-        56).  high concentrations KREN1-CBP fusion protein <br /> tosomes remained (Fig. 3E F). tet-dependent tran-           isolated insect cell expression showed vitro specific <br /> scriptional knockdown single remaining KREPA3 gene           U-deletion endonuclease activity presence BFs resulted complete loss editosomes, loss          KREPA3 (26). addition, endonuclease activities remain <br /> edited, unedited, mRNAs, consequently loss         following knockdown KREPA3 expression detected <br /> vitro editing activities. Exclusive expression TAP-tagged         &#226;&#172;&#402;20 40S complexes, activity levels propor- <br /> KREPA3 mutated ZFs OB-fold                tional editosome KREPA3 levels (determined <br /> deleted lethal, e., did rescue cell growth inac-      phosphorimager quantitation normalized KREPA1 tivation WT KREPA3 expression. Exclusive expression            KREPA2 [data shown]). Similarly, endonuclease activity <br /> TAP-tagged WT KREPA3 protein rescued cell growth, al-                detected 20 40S editosomes studies inhibited level. RNA editing somewhat            knock expression editosome components hibited tagged WT cells dramatically inhibited     shift editosomes lower S values (19, 29, 48). contrast, <br /> cells exclusively expressing mutated truncated KREPA3             mutations KREPA3 Zn fingers affect editosome structure <br /> proteins. Tagged KREPA3 proteins ZFs                stability discussed  remaining edito- <br /> mutated incorporated 20S editosomes            somes retain endonuclease editing catalytic ac- <br /> vitro U-insertion/ligation, U-deletion/ligation, insertion       tivities.  KREPA3 affect, essen- <br />  VOL. 28, 2008                                         KREPA3 ZFs OB-FOLD ESSENTIAL RNA EDITING                        6951 <br />  <br />  <br /> tial  editing endonuclease activities. &#226;&#171;&#185;1 U insertion    critical stability insertion deletion subcom- &#226;&#171;&#186;3 U deletion products increased KREPA3                 plexes, respectively (14, 19, 37). Knockdown KREPA1 repression (Fig. 3C D), implying KREPA3               KREPA2 does result dramatic loss editosomes enhance coordinate activities editing           shift lower S values consistent loss zymes, similar KREPA1 KREPA2 (15, 47).               insertion deletion subcomplexes. Mutation ZFs sults, reconstitution endonuclease activity        KREPA2 (TbMP63) ortholog Leishmania (LC-4) resulted supplementation KREPA3-depleted extracts             disruption editosome (25), implying complex stabilizing <br /> combinant KREPA3 reported Law et al. (30), suggests          role similar ZFs KREPA3. partial KREPA3 <br /> KREPA3 enhances needed endonuclease activity ei-           knockdown PFs resulted KREPA1 insertion subcomplexes <br /> ther indirectly effect editosome structure      smaller S value KREPA2 deletion subcomplexes (Fig. <br /> direct interaction KREN endonucleases. addition         3B). Correspondingly, KREPA1 RNAi knockdown results recombinant KREPA3 restored endonucle-             larger (37) subcomplexes, KREPA2 RNAi knockdowns <br /> ase editing activities KREPA3-depleted extracts assem-         results smaller (&#226;&#172;&#402;5S) subcomplexes (19). data bling residual subcomplexes &#226;&#172;&#402;20S editing complexes.         suggest deletion subcomplex stably associated <br />    KREPA3 essential editosome structure stability,        proteins insertion subcomplex, possibly editosomes disrupted KREPA3 RNAi knockdown              proteins KREPB4 KREPB5 PFs lost BFs transcription inactivation.         endonuclease subcomplex. <br /> difference likely reflects greater reduction KREPA3                KREPA3, KREPA4, KREPA6, possibly KREPA5 <br /> mRNA protein levels  quantitative PCR          proteins appear form structural core editosome studies reveal somewhat greater knockdown KREPA3             bridges insertion deletion subcomplexes associa- BFs PFs, KREPA3 protein faintly detectable        tion KREPA1 KREPA2 (Fig. 1) (29, 46, 47, 54). PF BF Western blots (Fig. 3B versus 4B Fig. 4A).         core appears link endonuclease subcomplex addition, reduction edited mRNA generally              KREPA3 KREPB5 interaction. editosome disruption <br /> greater BF PF knockdowns. Edited cyB mRNA            results expression KREPA3 C-terminal tag <br /> undetectable BFs, edited COII mRNA reduced                illustrates KREPA3 located inner BFs PFs. probably reflects             editosome tag interfere normal <br /> developmental regulation editing little    editosome structure (Fig. 6A). shift tagged WT edited mRNAs BFs (5, 17). studies        KREPA3 higher S regions gradient repression <br /> <span id='am-1' about='oboInOwl:date' typeof='owl:Thing'>date</span> revealed sedimentation composition differ-           untagged KREPA3 indicates integrate edi- <br /> ences BF PF editosomes, composition             tosomes competitive disadvantage editosome differences life cycle stages        untagged KREPA3. TAP tag inhibited cell growth (Fig. <br /> excluded. ZFs important &#226;&#172;&#402;20S editosome stabil-          5B), replacement short c-myc tag resulted cells <br /> ity. KREPA3 mutated ZFs gets incorporated edito-           grew normal rate (data shown), suggesting somes, abundance complexes diminished            effect tag structure. Despite effects, subcomplexes generated. Exclusive expression              tagged KREPA3 mutated ZFs integrate <br /> KREPA3 OB-fold results virtual absence         editosomes, elimination OB-fold editosomes. indicates proteins incorpo-       abolished integration interaction rated editosomes degraded.                                  KREPA1, KREPA2, KREPA6 (Fig. 8A B).  <br />    dramatic loss editosomes KREPA3 knockdown             editosome proteins LC-MS/MS asso- <br /> reported mirrors similar results knockdown KREPA4,        ciated purified TAP-tagged KREPA3&#226;&#338;&#172;OB (data KREPA6, KREPB4, KREPB5 (4, 29, 46, 54, 58) suggests           shown).  OB-fold critical KREPA3&#226;&#8364;&#8482;s interaction network interactions proteins    editosome proteins. reported  required editosome stability assembly. loss   KREPA3, KREPA4, KREPA6, studied editosome proteins knockdown       KREPA5, form network interactions involve OB- <br /> does appear changes mRNA levels          folds   Schnaufer, unpublished data).  illustrated <br /> proteins (58; study) instability degra-    effect expression KREPA3 OB-fold <br /> dation editosome proteins incorporated          deleted, OB-folds proteins appear function editosomes. reported  yeast hybrid analyses         protein-protein interaction.  does preclude <br /> showed direct interaction KREPA3 KREPA2,                 possibility OB-fold domain KREPA3 KREPA6, KREPB5 showed direct interaction             KREPA proteins affect substrate recognition, <br /> tween KREPA6 KREPA1, KREPA2, KREPA3,                         binding, translocation, suggested KREPA4   Schnaufer, unpublished data). addition,       KREPA1 (TbMP81) KREPA2 (TbMP63) (47, 62). detect KREPA6 copurifying &#226;&#172;&#402;5S TAP-tagged                      Editosomes mutated KREPA3 ZFs, stable, <br /> KREPA3 subcomplexes using LC-MS/MS analysis, indicating            capable catalyzing endonuclease, 3&#226;&#172;&#732; TUTase, 3&#226;&#172;&#732; <br /> high-affinity interaction KREPA3 KREPA6 (data            exoUase, RNA ligase steps editing vitro. Overexpres- shown). Previous findings showed KRET2 KREL2            sion TAP-tagged ZF mutants KREPA1, KREPA2, <br /> copurify tagged KREPA1 KREX2 KREL1 copurify             KREPA3 PFs did exhibit dominant-negative tagged KREPA2 insertion deletion editosome sub-          effect (data shown).  KREPA3 ZF muta- <br /> complexes, respectively (47). KREPA1 KREPA2, like                tions block editing vivo lethal exclusively <br /> KREPA3, ZFs C-terminal OB-fold            expressed. KREPA3 binds RNA (8), likely possibility  6952       GUO ET AL.                                                                                                                                 MOL. CELL. BIOL. <br />  <br />  ZFs function RNA recognition binding. C2H2                                   specific U-deletion RNA editing, REL2 RNA ligase specific                                                                                              U-insertion editing? J. Biol. Chem. 278:27570&#226;&#8364;&#8220;27574. <br /> ZFs general nonspecifically bind dsRNA helix                           17.   Hannaert, V., F. Bringaud, F. R. Opperdoes, P.  Michels. 2003. <br /> bone specifically recognize individual bases bulge                              Evolution energy metabolism compartmentation Kinetoplastida. structurally rigid element (51).  KREPA3                                  Kinetoplastid Biol. Dis. 2:11&#226;&#8364;&#8220;40. <br />                                                                                        18.   Harris, M. E., D. R. Moore, S. L. Hajduk. 1990. Addition uridines ZFs bind gRNA/pre-mRNA duplex sequence-                                         edited RNAs trypanosome mitochondria occurs independently tran- <br /> nonspecific manner conserved secondary structure.                                scription. J. Biol. Chem. 265:11368&#226;&#8364;&#8220;11376. function editing processivity. roles                       19.   Huang, C. E., S. F. O&#226;&#8364;&#8482;Hearn, B. Sollner-Webb. 2002. Assembly                                                                                              function RNA editing complex Trypanosoma brucei requires band ZFs differ mutation ZF greater                              III protein. Mol. Cell. Biol. 22:3194&#226;&#8364;&#8220;3203. <br /> effect tagged protein editosome                               20.   Igo, R. P., Jr., S. S. Palazzo, M. L. K. Burgess,  K. Panigrahi, K. <br />                                                                                              Stuart. 2000. Uridylate addition RNA ligation contribute speci- <br /> stability, mutation inhibited growth.                                 ficity kinteoplastid insertion RNA editing. Mol. Cell. Biol. 20:8447&#226;&#8364;&#8220;8457. function ZFs KREPA1                                 21.   Igo, R. P., Jr., D. S. Weston, N. L. Ernst,  K. Panigrahi, R. Salavati, KREPA2 total U1-like Zn fingers                                K. Stuart. 2002. Role uridylate-specific exoribonuclease activity                                                                                              Trypanosoma brucei RNA editing. Eukaryot. Cell 1:112&#226;&#8364;&#8220;118. <br /> KREN KREPB proteins shuttle substrate RNA                              22.   Iuchi, S. 2001. classes C2H2 zinc finger proteins. Cell Mol. Life Sci. editosome catalytic sites accomplish editing                                 58:625&#226;&#8364;&#8220;635. <br /> multiple sites, including insertion deletion sites.                           23.   Jensen, B. C., C. T. Kifer, D. L. Brekken,  C. Randall, Q. Wang, B. L. <br />                                                                                              Drees, M. Parsons. 2006. Characterization protein kinase CK2                                                                                              Trypanosoma brucei. Mol. Biochem. Parasitol. 151:28&#226;&#8364;&#8220;40. <br />                           ACKNOWLEDGMENTS                                              24.   Kable, M. L., S. D. Seiwert, S. Heidmann, K. Stuart. 1996. RNA editing: <br />                                                                                              mechanism gRNA-specified uridylate insertion precursor mRNA. <br />   study supported NIH grant AI014012 K.D.S.                                Science 273:1189&#226;&#8364;&#8220;1195. <br /> search conducted using equipment possible Economic                     25.   Kang, X.,  M. Falick, R. E. Nelson, G. Gao, K. Rogers, R. Aphasizhev, Development Administration-U.S. Department Commerce                               L. Simpson. 2004. Disruption zinc finger motifs Leishmania <br /> M. J. Murdock Charitable Trust.                                                              tarentolae LC-4 (&#226;&#171;&#189;TbMP63) L-complex editing protein affects stability   thank J. Carnes help real-time PCR,  Schnaufer                           L-complex. J. Biol. Chem. 279:3893&#226;&#8364;&#8220;3899. <br /> advice cell line construction, M. Parsons MAb66.                    26.   Kang, X., G. Gao, K. Rogers,  M. Falick, S. Zhou, L. Simpson. 2006. <br />                                                                                              Reconstitution round <span id='am-41' about='obo:IMR_0200021' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-42' property="rdfs:label" content="Uridine" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasDbXref" content="KEGG:C00299" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:id" content="IMR:0200021" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>uridine</span>-deletion RNA editing  <br /> thank members Stuart laboratory extensive helpful                             combinant proteins. Proc. Natl. Acad. Sci. USA 103:13944&#226;&#8364;&#8220;13949. <br /> discussion.                                                                            27.   Kang, X., K. Rogers, G. Gao,  M. Falick, S. Zhou, L. Simpson. 2005. <br />                                                                                              Reconstitution uridine-deletion precleaved RNA editing recom- <br />                                  REFERENCES                                                  binant enzymes. Proc. Natl. Acad. Sci. USA 102:1017&#226;&#8364;&#8220;1022. <br />  1. Agrawal, V., K. V. Kishan. 2003. OB-fold: growing bigger functional       28.   Law, J. , C. E. Huang, S. F. O&#226;&#8364;&#8482;Hearn, B. Sollner-Webb. 2005.     consistency. Curr. Protein Pept. Sci. 4:195&#226;&#8364;&#8220;206.                                         Trypanosoma brucei RNA editing, band II enables recognition specifically  2. Aphasizhev, R.,  Aphasizheva, R. E. Nelson, L. Simpson. 2003.                    step U insertion cycle. Mol. Cell. Biol. 25:2785&#226;&#8364;&#8220;2794. <br />     100-kD complex RNA-binding proteins mitochondria Leish-             29.   Law, J. , S. O&#226;&#8364;&#8482;Hearn, B. Sollner-Webb. 2007. Trypanosoma brucei <br />     mania tarentolae catalyzes RNA annealing interacts RNA                  RNA editing, TbMP18 (band VII) critical editosome integrity     editing components. RNA 9:62&#226;&#8364;&#8220;76.                                                         insertional deletional cleavages. Mol. Cell. Biol. 27:777&#226;&#8364;&#8220;787. <br />  3. Aphasizhev, R.,  Aphasizheva, L. Simpson. 2003. tale TUTases.       30.   Law, J. , S. F. O&#226;&#8364;&#8482;Hearn, B. Sollner-Webb. 2008. Trypanosoma brucei <br />     Proc. Natl. Acad. Sci. USA 100:10617&#226;&#8364;&#8220;10622.                                              RNA editing protein TbMP42 (band VI) crucial endonucleolytic <br />  4. Babbarwal, V. K., M. Fleck, N. L. Ernst,  Schnaufer, K. D. Stuart.                 cleavages subsequent steps U-deletion U-insertion. RNA. <br />     2007. essential role KREPB4 RNA editing structural integrity                14:1187&#226;&#8364;&#8220;1200. <br />     editosome Trypanosoma brucei. RNA 13:737&#226;&#8364;&#8220;744.                            31.   Lu, D., M.  Searles,  Klug. 2003. Crystal structure zinc-finger- <br />  5. Besteiro, S., M. P. Barrett, L. Riviere, F. Bringaud. 2005. Energy gen-              RNA complex reveals modes molecular recognition. Nature 426:96&#226;&#8364;&#8220; <br />     eration insect stages Trypanosoma brucei: metabolism flux. Trends               100. <br />     Parasitol. 21:185&#226;&#8364;&#8220;191.                                                             32.   Madison-Antenucci, S., J. Grams, S. L. Hajduk. 2002. Editing machines: <br />  6. Blum, B., N. Bakalara, L. Simpson. 1990. model RNA editing                  complexities trypanosome RNA editing. Cell 108:435&#226;&#8364;&#8220;438. <br />     kinetoplastid mitochondria: &#226;&#8364;&#339;guide&#226;&#8364;? RNA molecules transcribed max-            33.   Miller, M. M., K. Halbig, J. Cruz-Reyes, L. K. Read. 2006. RBP16 <br />     icircle DNA provide edited information. Cell 60:189&#226;&#8364;&#8220;198.                             stimulates trypanosome RNA editing vitro early step editing <br />  7. Brayer, K. J., D. J. Segal. 2008. fingers DNA: protein-             reaction. RNA 12:1292&#226;&#8364;&#8220;1303. <br />     protein interactions mediated C2H2 zinc finger domains. Cell Biochem.           34.   Muller, U. F., L. Lambert, H. U. Goringer. 2001. Annealing RNA <br />     Biophys. 50:111&#226;&#8364;&#8220;131.                                                                     editing substrates facilitated guide RNA-binding protein gBP21. EMBO <br />  8. Brecht, M., M. Niemann, E. Schlu    &#194;&#168;ter, U. F. Mu  &#194;&#168;ller, K. Stuart, H. U.          J. 20:1394&#226;&#8364;&#8220;1404. <br />     ringer. 2005. TbMP42, protein component RNA editing complex            35.   Murzin,  G. 1993. OB(oligonucleotide/oligosaccharide binding)-fold: com- <br />     African trypanosomes endo-exoribonuclease activity. Mol. Cell 17:                 mon structural functional solution non-homologous sequences. <br />     621&#226;&#8364;&#8220;630.                                                                                 EMBO J. 12:861&#226;&#8364;&#8220;867. <br />  9. Carnes, J., K. Stuart. 2007. Working  RNA editing ma-             36.   Niemann, M., M. Brecht, E. Schluter, K. Weitzel, M. Zacharias, H. U. <br />     chinery Trypanosoma brucei, p. 143&#226;&#8364;&#8220;164. H. U.      &#194;&#168;ringer (ed.), RNA           Goringer. 2008. TbMP42 structure-sensitive ribonuclease likely <br />     editing, vol. 20. Springer Verlag, Heidelberg, Germany.                                  follows metal <span id='am-2' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-3' property="rdfs:label" content="ion" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-6' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-7' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span>ion</span> catalysis mechanism. Nucleic Acids Res. 36:4465&#226;&#8364;&#8220;4473. <br /> 10. Carnes, J., J. R. Trotter, N. L. Ernst,  G. Steinberg, K. Stuart. 2005.      37.   O&#226;&#8364;&#8482;Hearn, S., C. E. Huang, M. Hemann,  Zhelonkina, B. Sollner-Webb. <br />     essential RNase III insertion editing endonuclease Trypanosoma bru-                2003. Trypanosoma brucei RNA editing complex: band II structurally <br />     cei. Proc. Natl. Acad. Sci. USA 102:16614&#226;&#8364;&#8220;16619.                                         critical maintains band V ligase, nonessential. Mol. Cell. Biol. <br /> 11. Carnes, J., J. R. Trotter,  Peltan, M. Fleck, K. Stuart. 2008. RNA                 23:7909&#226;&#8364;&#8220;7919. <br />     editing Trypanosoma brucei requires different editosomes. Mol. Cell.      38.   Panigrahi,  K., N. L. Ernst, G. J. Domingo, M. Fleck, R. Salavati, K. D. <br />     Biol. 28:122&#226;&#8364;&#8220;130.                                                                        Stuart. 2006. Compositionally functionally distinct editosomes 12. Cruz-Reyes, J., B. Sollner-Webb. 1996. Trypanosome U-deletional RNA                  Trypanosoma brucei. RNA 12:1038&#226;&#8364;&#8220;1049. <br />     editing involves guide RNA-directed endonuclease cleavage, terminal U              39.   Panigrahi,  K.,  Schnaufer, N. Carmean, R. P. Igo, Jr., S. P. Gygi, N. L. <br />     exonuclease, RNA ligase activities. Proc. Natl. Acad. Sci. USA 93:8901&#226;&#8364;&#8220;              Ernst, S. S. Palazzo, D. S. Weston, R. Aebersold, R. Salavati, K. D. <br />     8906.                                                                                    Stuart. 2001. related proteins Trypanosoma brucei RNA editing <br /> 13. Cruz-Reyes, J.,  Zhelonkina, L. Rusche&#194;&#180;, B. Sollner-Webb. 2001. Try-               complex. Mol. Cell. Biol. 21:6833&#226;&#8364;&#8220;6840. <br />     panosome RNA editing: simple guide RNA features enhance U deletion                 40.   Panigrahi,  K.,  Schnaufer, N. L. Ernst, B. Wang, N. Carmean, R. <br />     100-fold. Mol. Cell. Biol. 21:884&#226;&#8364;&#8220;892.                                                   Salavati, K. Stuart. 2003. Identification novel components 14. Drozdz, M., S. S. Palazzo, R. Salavati, J. O&#226;&#8364;&#8482;Rear, C. Clayton, K. Stuart.            Trypanosoma brucei editosomes. RNA 9:484&#226;&#8364;&#8220;492. <br />     2002. TbMP81 required RNA editing Trypanosoma brucei. EMBO J.            41.   Parker, H. L., T. Hill, K. Alexander, N. B. Murphy, W. R. Fish, M. <br />     21:1791&#226;&#8364;&#8220;1799.                                                                            Parsons. 1995. genes isozymes: gene conversion 15. Ernst, N. L., B. Panicucci, R. P. Igo, Jr.,  K. Panigrahi, R. Salavati, K.         compartmentalization expression phosphoglycerate kinases     Stuart. 2003. TbMP57 3&#226;&#172;&#732; terminal uridylyl transferase (TUTase)               Trypanosoma (Nannomonas) congolense. Mol. Biochem. Parasitol. 69:269&#226;&#8364;&#8220; <br />     Trypanosoma brucei editosome. Mol. Cell 11:1525&#226;&#8364;&#8220;1536.                                    279. <br /> 16. Gao, G., L. Simpson. 2003. Trypanosoma brucei REL1 RNA ligase           42.   Pelletier, M., L. K. Read. 2003. RBP16 multifunctional gene regu- <br />  VOL. 28, 2008                                                         KREPA3 ZFs OB-FOLD ESSENTIAL RNA EDITING                                           6953 <br />  <br />       latory protein involved editing stabilization specific mitochondrial          management: RNA editing trypanosomes. Trends Biochem. Sci. 30:97&#226;&#8364;&#8220; <br />       mRNAs Trypanosoma brucei. RNA 9:457&#226;&#8364;&#8220;468.                                             105. <br /> 43.   Pfaffl, M. W. 2001. new mathematical model relative quantification       54.   Tarun, S. , Jr.,  Schnaufer, N. L. Ernst, R. Proff, J. Deng, W. Hol,       real-time RT-PCR. Nucleic Acids Res. 29:e45.                                            K. Stuart. 2008. KREPA6 RNA binding protein essential editosome <br /> 44.   Ramakers, C., J. M. Ruijter, R. H. L. Deprez,  F. M. Moorman. 2003.               integrity survival Trypanosoma brucei. RNA 14:347&#226;&#8364;&#8220;358. <br />       Assumption-free analysis quantitative real-time polymerase chain reaction      55.   Theobald, D. L., R. M. Mitton-Fry, D. S. Wuttke. 2003. Nucleic acid <br />       (PCR) data. Neurosci. Lett. 339:62&#226;&#8364;&#8220;66.                                                  recognition OB-fold proteins. Annu. Rev. Biophys. Biomol. Struct. 32: <br /> 45.   Rogers, K., G. Gao, L. Simpson. 2007. Uridylate-specific 3&#226;&#172;&#732;-5&#226;&#172;&#732; exoribo-             115&#226;&#8364;&#8220;133. <br />       nucleases involved uridylate-deletion RNA editing trypanosomatid            56.   Trotter, J. R., N. L. Ernst, J. Carnes, B. Panicucci, K. Stuart. 2005.       mitochondria. J. Biol. Chem. 282:29073&#226;&#8364;&#8220;29080.                                           deletion site editing endonuclease Trypanosoma brucei. Mol. Cell 20:403&#226;&#8364;&#8220; <br /> 46.   Salavati, R., N. L. Ernst, J. O&#226;&#8364;&#8482;Rear, T. Gilliam, S. Tarun, Jr., K. Stuart.         412. <br />       2006. KREPA4, RNA binding protein essential editosome integrity            57.   Vanhamme, L., D. Perez-Morga, C. Marchal, D. Speijer, L. Lambert, M. <br />       survival Trypanosoma brucei. RNA 12:819&#226;&#8364;&#8220;831.                                     Geuskens, S. Alexandre, N. Isma&#196;&#177;&#194;&#168;li, U.  &#194;&#168;ringer, R. Benne, E. Pays. <br />                                                                                               1998. Trypanosoma brucei TBRGG1, mitochondrial oligo(U)-binding pro- <br /> 47.   Schnaufer, , N. Ernst, J. O&#226;&#8364;&#8482;Rear, R. Salavati, K. Stuart. 2003. Sepa- <br />                                                                                               tein colocalizes vitro RNA editing activity. J. Biol. Chem. <br />       rate insertion deletion sub-complexes Trypanosoma brucei RNA <br />                                                                                               273:21825&#226;&#8364;&#8220;21833. <br />       editing complex. Mol. Cell 12:307&#226;&#8364;&#8220;319. <br />                                                                                         58.   Wang, B., N. L. Ernst, S. S. Palazzo,  K. Panigrahi, R. Salavati, K. <br /> 48.   Schnaufer, ,  K. Panigrahi, B. Panicucci, R. P. Igo, Jr., R. Salavati,                                                                                               Stuart. 2003. TbMP44 essential RNA editing structural integrity       K. Stuart. 2001. RNA ligase essential RNA editing survival                                                                                               editosome Trypanosoma brucei. Eukaryot. Cell 2:578&#226;&#8364;&#8220;587. <br />       bloodstream form Trypanosoma brucei. Science 291:2159&#226;&#8364;&#8220;2162.                    59.   Wang, , J. C. Morris, M. E. Drew, P. T. Englund. 2000. Inhibition 49.   Seiwert, S. D., S. Heidmann, K. Stuart. 1996. Direct visualization               Trypanosoma brucei gene expression RNA interference using integrat- <br />       uridylate deletion vitro suggests mechanism kinetoplastid RNA                  able vector opposing T7 promoters. J. Biol. Chem. 275:40174&#226;&#8364;&#8220;40179. <br />       editing. Cell 84:831&#226;&#8364;&#8220;841.                                                         60.   Wirtz, E., S. Leal, C. Ochatt, G.  M. Cross. 1999. tightly regulated <br /> 50.   Simpson, L., R. Aphasizhev, G. Gao, X. Kang. 2004. Mitochondrial                    inducible expression conditional gene knockouts dominant- <br />       proteins complexes Leishmania Trypanosoma involved U-                     negative genetics Trypanosoma brucei. Mol. Biochem. Parasitol. 99:89&#226;&#8364;&#8220; <br />       insertion/deletion RNA editing. RNA. 10:159&#226;&#8364;&#8220;170.                                        101. <br /> 51.   Stefl, R., L. Skrisovska, F. H. Allain. 2005. RNA sequence- shape-        61.   Wolfe, S. , L. Nekludova, C. O. Pabo. 2000. DNA recognition       dependent recognition proteins ribonucleoprotein particle. EMBO               Cys2His2 zinc finger proteins. Annu. Rev. Biophys. Biomol. Struct. 29:183&#226;&#8364;&#8220; <br />       Rep. 6:33&#226;&#8364;&#8220;38.                                                                           212. <br /> 52.   Stuart, K., T. E. Allen, S. Heidmann, S. D. Seiwert. 1997. RNA editing        62.   Worthey, E. ,  Schnaufer,  S. Mian, K. Stuart, R. Salavati. 2003. <br />       kinetoplastid protozoa. Microbiol. Mol. Biol. Rev. 61:105&#226;&#8364;&#8220;120.                       Comparative analysis editosome proteins trypanosomatids. Nucleic <br /> 53.   Stuart, K. D.,  Schnaufer, N. L. Ernst,  K. Panigrahi <br /> </body></html>